Autism
Completed Trials
Investigators are researching the impact of Microbiota Transfer Therapy on Autism and gastrointestinal symptoms in patients with Autism. A phase 1 clinical trial found Autism symptoms reduced nearly 50% two years after microbiota therapy. Read more about the initial trial.
Additional information about the Autism Research Program at Arizona State University is available here.
ASU Researchers Dr. James Adams& Dr. Rosa Krajmalnik-Brown share results from their research.
Hear from patients enrolled in the trial and here.
Achieving Cures Together is tax exempt pursuant to IRC Section 501(c)(3). Contributions are deductible to the extent allowed by law.
